Board of Directors

J. Christopher Brengard — CEO, U.S. Renal Care
U.S. Renal Care’s management team has been headed by Chris Brengard since 2000. Chris’ credentials include serving as Select Medical Corporation’s Vice President of Outpatient Operations from 1998 to 2000. In addition, in 1992 Mr. Brengard was the founder and CEO of MediFit Rehabilitation Group in Houston Texas until 1998. Prior to MediFit, he held various positions with Continental Medical Systems in Jonesboro Arkansas.

Jack F. Egan — Sr. Vice President, U.S. Renal Care
Jack Egan has been on the U. S. Renal Care management team since 2000. Mr. Egan’s credentials include serving in Tampa Florida as Select Medical Corporation’s Sr. Vice President from 1997 to 2000. From 1991 to 1997, he was President/COO of RehabWorks, Inc., a subsidiary of Continental Medical Systems. Mr. Egan also served as CFO/EVP of RehabWorks in Clearwater Florida from 1987 until 1991.

Martin F. Jackson — Chief Financial Officer, Select Medical Corporation
Martin F. Jackson has served as Senior Vice President and Chief Financial Officer since May 1999. Mr. Jackson previously served as a Managing Director of the Healthcare Investment Banking Group for CIBC Oppenheimer from January 1997 to May 1999. Prior to that time, he served as Senior Vice President, Health Care Finance with McDonald & Company Securities, Inc. from January 1994 to January 1997. Prior to 1994, Mr. Jackson held senior financial positions with Van Kampen Merritt, Touche Ross, Honeywell and L’Nard Associates.

Eugene Hill — General Partner, SV Life Sciences
Eugene Hill joined SVLS in 1999. He was previously a Partner at Accel Partners in Palo Alto, California for five years, where he was responsible for 13 investments in early stage healthcare service and healthcare information technology companies. He is currently on the Board of Synarc, Cadent, Interplan Health, Patient Care, Medifacts and US Renal Care.

Prior to joining Accel Partners, Eugene held several senior management positions, most recently, President of Behavioral Health at United HealthCare Corporation, CEO and President of US Behavioral Health and President and Chairman of Sierra Health and Life Insurance Company. Eugene has 19 years of operating experience in the US healthcare services market. Eugene has a BA from Middlebury College and an MBA from Boston University.

David Ward — General Partner, Salix Ventures
David Ward founded Salix Ventures with Chris Grant in 1997 and works in the Nashville, Tennessee office. Prior to Salix, David was instrumental in the start-up and growth of two companies. As Vice President of Development at MedCath (Nasdaq:MDTH), a cardiovascular services provider, he was instrumental in conceiving, planning, and executing the company’s strategy for developing specialty heart hospitals, the first independent, freestanding specialized facilities in the United States dedicated to cardiovascular care.

David commenced his career at Bain Capital and was part of a team that conceived, developed, and implemented the business plan for MediVision. As Director of Development and then Vice President of Operations, David acquired, developed, and later managed, numerous eye surgery centers and their affiliated practices. After MediVision was acquired by Medical Care International, David served as Medical Care’s Vice President of Managed Care.

David graduated Phi Beta Kappa from Stanford University in 1979 with an A.B. in economics and received his J.D. and M.B.A. from Stanford University in 1983.

John P. Byrnes — Chief Executive Officer, Lincare, Inc.
John P. Byrnes has served as the Chief Executive Officer of Lincare, Inc. (NASD:LNCR) since January 1997, a Director of the Company since May 1997, and Chairman of the Board since March 2000. Lincare, Inc. is a leading provider of oxygen and other respiratory therapy services delivered to patients in the home, with revenues in excess of $1 Billion per year. Mr.Byrnes also served as the company’s President from June 1996 until April 2003. Mr. Byrnes is a Director of Kinetic Concepts, Inc. (NYSE:KCI), a global medical technology company with leadership positions in advanced wound care and therapeutic services.

Barry C. Cosgrove — Private Investor
Barry C. Cosgrove is a businessman, attorney and charitable director who, for the past 20 years, has founded and led public and private enterprises. Mr. Cosgrove was a founder of DaVita, Inc. (NYSE: DVA), the world’s largest independent operator of renal dialysis facilities. From 1994 until September 2000, Mr. Cosgrove served in various senior executive positions with DaVita, including Senior Vice President and General Counsel, and was primarily responsible for acquisitions that fueled DaVita’s growth. Prior to joining DaVita, Mr. Cosgrove served as Executive Vice President of Total Pharmaceutical Care, Inc., until its sale in late 1993 to Apria Healthcare. Prior to 1993 was a senior executive with McGaw Labs in Irvine, California. Currently, Mr. Cosgrove is President, CEO and Chairman of the Board of Blackmore Partners, a private equity and holding company. Mr. Cosgrove serves as a member of the National Assembly of Board Members of the Alzheimer’s Association.

Bryan Cressey — Partner, Cressey & Company
Bryan Cressey, began his career with First Chicago Equity Group and was one of the founders of the firm that became Golder, Thoma, Cressey, Rauner. He co-founded TCB in 1998. His industry consolidation leadership has been recognized by Fortune and Time magazines, and his particular expertise in the healthcare services field has become widely acknowledged. A member of the Chicago Area Entrepreneurship Hall of Fame, Bryan received his BS in Economics at the University of Washington and earned MBA from Harvard Business School and JD from Harvard Law School.